Medications

AI use in pharmacotherapy still in the early stages

Detecting drug interactions, discovering new drugs, predicting treatment response, optimizing doses–the list of the potential benefits of artificial intelligence (AI) for pharmacotherapy is long and promising.

Diseases, Conditions, Syndromes

Raising awareness of spina bifida

Spina bifida is the most common birth defect of the central nervous system and the second most common of all structural birth defects. To learn more about it, Baylor College of Medicine's From the Labs sat with Dr. Richard ...

Neuroscience

Examining the gene-environment interactions that drive autism

People with autism spectrum disorders all have characteristic behavioral difficulties. Nevertheless, the important heterogeneity of their symptoms remains one of the major questions for scientists and physicians. While a ...

Oncology & Cancer

How inflammatory signalling molecules contribute to carcinogenesis

A team of MedUni Vienna researchers led by Johannes A. Schmid at the Center for Physiology and Pharmacology, Institute of Vascular Biology and Thrombosis Research, has managed to identify a previously unknown molecular connection ...

page 1 from 6